CNS Vital Signs has rapidly become a world leader in the delivery and management of computerized cognitive testing in international clinical trial research. Over 2000 investigators have utilized the CNS Vital Sign platform over the past 5 years across a large spectrum of diseases. Our sponsors span the range of Fortune 500 companies to the most virtual of Biotechs. Our experience spans the spectrum of Phase I-IV research, investigator initiated trials, government research, and extensive academic research.
CNS Vital Signs provides researchers (Pharmaceutical Companies, Biotechs, Nutraceuticals, Academic Researchers, etc) with leading edge neurocognitive assessment technologies that allow sponsors and investigators to rapidly assess a patient's brain function. Our extensive library of computerized neuropsychological tests and evidence-based rating scales allow researchers to efficiently evaluate a broader view of neurocognition, behavioral health, comorbidities, or neurobehavioral health status.
CNS Vital Signs offers researchers a flexible testing platform. In addition to a local running software option (laptop or desktop), more and more sponsors are taking advantage of the CNS Vital Signs web platform, which introduces tremendous efficiencies to the management of cognitive testing across the clinical trial setting. The web based platform produces sound data while saving time and cost. Real-time assessment of data results allows for better management of sites and early detection of data trends that could affect important trial endpoints. Early detection of trends can play a critical role to proactively tackle potential issues in your study.
CNS Vital Signs CEO, Alan Boyd's interviewed on the "Conversations with Industry Leaders" section of the Trial Acceleration Institute website. Listen...
CNS Vital Signs provides a variety of solutions to meet most any researcher's neurocognitive testing needs. The CNS Vital Signs test battery is available in over 50 languages and has been utilized as a research tool in over 35 countries worldwide.
To date, researchers have used CNS Vital Signs to measure drug and treatment differences in many disease and therapeutic areas. CNS Vital Signs' precise measurement of neurocognitive clinical endpoints helps researchers differentiate their compounds within an affordable budget. In addition, since the scored report is available immediately, timely inclusion / exclusion / randomization / safety decisions can be made by investigators at the site at the time of patient visit. There are other operational efficiencies CNS Vital Signs utilizes to solve the problems historically associated with large scale, worldwide clinical research implementation.
CNS Vital Signs has been solving the problem of implementing large multinational clinical research projects since 2004. Our customizable, easy to implement testing platforms allows sponsors to start neurocognitive testing in early stages and then test across until submission and into post approval safety studies.
As a service to clients, CNS Vital Signs provides consultation to determine neurocognitive domain selection and assist with protocol design. The test is sensitive to a variety of drug treatments and neurocognitive disorders including: AD/HD, MCI, Alzheimer's disease, Bipolar Depression, Brain Injury, Parkinson's disease, Schizophrenia, Stroke, Various dementias, and other diseases where neurocognitive deficit is associated with the study condition.
Choose from:
Afrikaans — Arabic — Bengali — Bulgarian — Cebuano — Chinese Simplified (China) — Chinese Simplified (Malaysia) — Chinese Traditional — Croatian — Czech — Danish — Dutch — English (United States) — English (United Kingdom) — Filipino — Finnish — French — French (Canada) — German — Greek — Gujarati — Hebrew — Hindi — Hungarian — Ilocano — Indonesian — Italian — Japanese — Kannada — Korean — Latvian — Malay — Malayalam — Marathi — Norwegian — Polish — Portuguese (Brazil) — Portuguese (Portugal) — Punjabi — Romanian — Russian — Serbian — Sesotho — Slovak — Spanish (Latin America) — Spanish (Mexico) — Spanish (Spain) — Swedish — Tagalog — Tamil — Telugu — Thai — Turkish — Ukrainian — Urdu — Xhosa — Zulu.
Data generated from CNS Vital Signs applications is easy to understand and describe. Treated like any lab data, sponsors can easily perform their own analysis. Most clients choose electronic data upload where the investigator site sends the data to hosted colocation centers. Electronic data options allow the sponsor to obtain their data quickly. CNS Vital Signs offers the ability to custom configure data collection methods to meet operational and research needs.
The choice of data collection method is designed to fit the way most any sponsor collects data. Here are examples of some common options:
Customizable Scales and Questionnaires can be added to your custom build to suit your research needs.
Students, interns, residents and fellows doing research receive additional discounts, as do academic and government groups. Research must be of scientific merit and a brief description of the project is necessary.
Pharmaceutical companies and other researchers requiring customization or additional language support should contact CNS Vital Signs directly with their specific requirements.
Learn More
Home
Clinical Practice
Clinical Trials
Academic Research
Publications
Reimbursement
Remote Test
Pricing
Contact
NEW Learn More Video
Sample Report
FAQs
How To
Forgot My Password
Products
KYBA
Webinar
Do You See the Signs™
CNS Vital Signs is a world leader in the design and development of neurocognitive and behavioral assessment tools and technologies. We provide clinicians and researchers with leading-edge technologies for improved neurocognitive and behavioral evaluation and management capabilities.
FDA Medical Device Registration Number: 3006559064
SOC2 Type 2 Compliant
Copyright 2025 CNS Vital Signs, LLC. All rights reserved.
Use of CNS Vital Signs Products and Website constitutes acceptance of the CNS Vital Signs Terms of Service and Privacy Policy.